The QualityStocks Daily Tuesday, June 30th, 2020

Today's Top 3 Investment Newsletters

MarketClub Analysis (POLA) +262.04%

StreetInsider (QUMU) +49.58%

QualityStocks (FTMR) +46.12%

The QualityStocks Daily Stock List

American BriVision (Holding) Corporation (ABVC)

Stock Day Media, Street Insider, Investor Point, AA Stocks, Internet Stock Review, TMXmoney, Wallet Investor, Corporate Information, 4-Traders, Stockhouse, Dividend Investor, TipRanks, Market Screener, Morningstar, Drug Discovery Online, TradingView, Stockopedia, Real Investment Advice, GlobeNewswire, Stockwatch, Financial Content, Simply Wall St, last10k, and Nasdaq reported beforehand on American BriVision (Holding) Corporation (ABVC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American BriVision (Holding) Corporation is a clinical stage biopharmaceutical company listed on the OTC Markets’ OTCQB. It is developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology. The Company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development. Founded in 2015, American BriVision is based in Fremont, California.

The Company focuses on using its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research institutions. These include Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center. American BriVision then centers on out-licensing the products to global pharmaceutical companies for pivotal Phase III studies and, eventually, generating worldwide sales.

American BriVision released positive clinical results in June of 2019 showing efficacy and safety for its ABV-1504 Phase II (Part 2) trial, under the U.S. Food and Drug Administration (FDA) and Taiwan FDA clinical protocol code of BLI-1005-002, in major depressive disorder (MDD). The study was a randomized, double-blind, placebo-controlled, multi-center trial. Sixty adult patients with confirmed moderate-to-severe MDD were treated with PDC-1421 low dose (380 mg), PDC-1421 high dose (2 x 380 mg), or placebo for 6 weeks, three times per day. PDC-1421 is the active pharmaceutical ingredient of ABV-1504.

PDC-1421 high dose (2 x 380 mg) met the prespecified primary endpoint by demonstrating a highly significant 13.2-point reduction in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score by Intention-To-Treat (ITT) analysis, averaged over the 6-week treatment period from baseline (overall treatment effect), versus a 9.2-point reduction in the placebo group. The results support further development of PDC-1421 in MDD. The low and high doses of PDC-1421 were safe and well tolerated with no serious adverse events.

Earlier this month, American BriVision announced the completion of patient enrollment of ABV-1505 Phase II Part I clinical trial for the treatment of adult attention-deficit hyperactivity disorder (ADHD). The new study will be conducted at the University of California San Francisco (UCSF) Medical Center. American BriVision said that ABV-1505, with the active pharmaceutical ingredient PDC-1421, has been successfully evaluated in a recently completed Phase II study conducted at Stanford University and five major medical centers in Taiwan for the treatment of major depressive disorder (MDD).

Dr. Howard Doong, Chief Executive Officer of American BriVision, said, “We are pleased that UCSF was able to complete the enrollment of the first six patients during this COVID-19 pandemic period. And we are optimistic that this Phase II Part I clinical trial will indicate therapeutic benefits and the promise of ABV-1505 for adults suffering from ADHD.”

American BriVision (Holding) Corporation (ABVC), closed Tuesday's trading session at $3.00, up 7.1429%, on 1,000 volume with 4 trades. The average volume for the last 3 months is 350 and the stock's 52-week low/high is $1.04999995/$12.00.

Artelo Biosciences, Inc. (ARTL)

NetworkNewsWire, StockPulse, Momentous News, Zacks, Stocks Herald, Health Technology Net, Stockhouse, Proactive Investors, Market Exclusive, EIN News, Accesswire, Stock Monitor, Street Insider, Stock Market Watch, Stockwatch, Trading View, last10k, PR Newswire, Simply Wall St, Proactive Investors, and Stockopedia reported earlier on Artelo Biosciences, Inc. (ARTL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company based in La Jolla, California. It focuses on the development of therapeutics that modulate the endocannabinoid system. The Company is quickly advancing a portfolio of widely applicable product candidates designed to address significant unmet needs in manifold diseases and conditions. These include cancer, pain, and inflammation. Founded in 2011, the Company previously went by the name Reactive Medical, Inc. It changed its name to Artelo Biosciences, Inc. in April of 2017. Artelo Biosciences lists on the NasdaqGS.

The Company’s belief is that a biopharmaceutical approach will lead to novel and high-impact therapeutics, which harness the full potential of the endocannabinoid system (ECS). The endocannabinoid system (ECS) is a widespread neuromodulatory system. It plays a vital role in human central nervous system (CNS) development, synaptic plasticity, and the response to endogenous and environmental insults.

Artelo’s business model is to develop numerous pharmacological approaches to ECS modulation. Candidate therapeutic compounds within its present portfolio are founded on targeting cannabinoid receptors and endocannabinoid transport inhibition. The Company’s pipeline includes many mechanisms for endocannabinoid system modulation. Specific programs now in development include ART27.13 – a high-potency GPCR Agonist (anorexia, cancer).

Programs in development also include ART12.11 - proprietary cocrystal (multiple indications), and ART26.12 – a FABP5 Inhibitor (cancer, pain). Two of Artelo Biosciences’ development programs were licensed from established and respected organizations. These organizations have already conducted pre-clinical research and, in some cases, clinical research.

Yesterday, Artelo Biosciences announced that it has expanded its existing research and global commercial license agreement with The Research Foundation For The State University of New York, Stony Brook. The Company has obtained exclusive rights to recently developed, third-generation fatty acid binding protein 5 (FABP5) inhibitors.

Artelo plans to choose a lead cancer therapeutic compound from these compounds, and also to identify more candidates for pain, inflammation, and other conditions, facilitating a potentially major expansion to its development pipeline. Many of the third generation FABP5 inhibitors have shown greater potency and/or selectivity to FABP5.

Mr. Gregory D. Gorgas, Artelo Biosciences’ President and Chief Executive Officer, stated, “We continue to believe in the promise of lipid signaling pathways as a target for cancer therapeutics. Expanding our agreement with Stony Brook to include additional third-generation FABP5 inhibitors that have shown encouraging pre-clinical results in cancer, inflammation and pain, provides a significant opportunity to both explore this potential and strategically prime our development pipeline.”

Artelo Biosciences, Inc. (ARTL), closed Tuesday's trading session at $1.21, off by 3.20%, on 204,008 volume with 627 trades. The average volume for the last 3 months is 226,478 and the stock's 52-week low/high is $0.610000014/$4.98999977.

n

Barksdale Resources Corp. (BRKCF)

321gold, Insider Tracking, Streetwise Reports, Investing News, Proactive Investors, Mining Stock Education, Market Screener, 4-Traders, MarketWatch, Nasdaq, Metals News, TMXmoney, OTC Markets, Accesswire, Barchart, Business Insider, Dividend Investor, Morningstar, Junior Mining Network, Seeking Alpha, FSC Wire, King World News, TradingView, Baystreet.ca, PR Newswire, and Stockhouse reported earlier on Barksdale Resources Corp. (BRKCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Barksdale Resources Corp. is a base metal exploration company headquartered in Vancouver, British Columbia. It focuses on the acquisition and exploration of highly prospective base metal projects in the United States. The Company’s projects are in the Patagonia mining district in southern Arizona. The Company formerly went by the name Barksdale Capital Corp. It changed its name to Barksdale Resources Corp. in February 2020. Barksdale Resources’ shares trade on the OTC Markets Group’s OTCQB.

Barksdale 's asset portfolio is situated within a world-class base metal district in southern Arizona and is surrounded by some of the world's largest mining companies. Barksdale concentrates on obtaining assets that provide a suitable mix of exploration potential, district scale property control, and optionality around potential exits. The Company’s Arizona assets include the San Antonio, Four Metals, and Sunnyside projects.

The San Antonio project is n the Patagonia Mountains of southern Arizona. The project is 100 percent owned by Barksdale and is about 25.5 km2 (6,300 acres). In addition, the Four Metals project is also in the Patagonia Mountains of southern Arizona. Barksdale Resources has an option to acquire a 100 percent interest in Four Metals. This is a 760-acre property surrounded by federal mineral claims held by South32.

The Sunnyside Project is in the Patagonia Mountains of southern Arizona, approximately an hour and a half drive south of Tucson. The project is about 21km2 (5,223 acres) and is cored by a large intrusive complex. The main near-term exploration target is a skarn situated on the northeast margin of the intrusive complex, which is likely to host copper-zinc-lead-silver mineralization interpreted to be the extension of the world-class Taylor deposit (South32).

This past April, Barksdale Resources announced that it made an aggregate US$25,000 cash payment and issued 136,986 common shares to Minquest Ltd. and Allegiant Gold Corp. at a deemed price of C$0.2577 per share. This payment confirms Barksdale's intention to continue with its existing option agreement on the 760-acre Four Metals project, situated 3km south of the Company's flagship Sunnyside project and 2km west of the 100 percent owned San Antonio project. The issued shares are subject to a four month hold period expiring August 22, 2020.

At the end of April, Barksdale Resource announced it was continuing to manage and respond to COVID-19 under the recommendations of health authorities and also national and local regulatory requirements. The Company said that there have been no material impacts to the timelines associated with permitting its exploration projects in Arizona as the United States Forest Service has transitioned to a remote work environment.

Barksdale Resources Corp. (BRKCF), closed Tuesday's trading session at $0.24, up 10.2435%, on 14,900 volume with 13 trades. The average volume for the last 3 months is 7,913 and the stock's 52-week low/high is $0.14/$0.569999992.

Mustang Bio, Inc. (MBIO)

Zacks, Stocktwits, Stocknews, BioPharmCatalyst, BioSpace, Market Chameleon, MacroTrends, Investors Observer, TipRanks, iwatchmarkets, GuruFocus, YCharts, Simply Wall St, Finviz, Market Screener, Stockhouse, DBT News, ETF.com, Seeking Alpha, Invest Million, Nasdaq, Morningstar, TMXmoney, and GlobeNewswire reported beforehand on Mustang Bio, Inc. (MBIO), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company listed on the NasdaqGM. It focuses on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The Company’s world class team in-licenses, develops, and manufactures next generation therapies for the ultimate benefit of patients. Mustang Bio expects to advance 2-3 new therapeutic candidates into the clinic annually. It has developed the manufacturing expertise required to develop and commercialize these therapies on a wide scale. Mustang Bio has its corporate headquarters in Worcester, Massachusetts.

The Company has partnered with leading medical institutions to advance the development of CAR T and CRISPR/Cas9-enhanced CAR T therapies across multiple cancers, and also a lentiviral gene therapy for XSCID. Mustang Bio aims to acquire rights to the above-mentioned technologies through licensing or otherwise acquiring an ownership interest, to fund research and development (R&D), and to out-license or bring the technologies to market.

Regarding the Company’s present Gene Therapy focus, X-linked severe combined immunodeficiency (XSCID) is an inherited disorder of the immune system. It occurs almost exclusively in males that diminishes and shortens the lifespan of males. Mustang Bio’s XSCID gene therapy, undergoing development through a collaboration with St. Jude involves ex vivo lentiviral transduction of patients’ own hematopoietic stem cells with a normal copy of the mutated gene. The process used is analogous to the manufacturing process for the Company’s CAR Ts.

Regarding Mustang Bio’s CAR T areas of focus, the Company brings significant expertise to the development of next generation CAR T cell therapy. Mustang is rapidly advancing several promising candidates designed to hit unique targets with first in class potential for hematologic and solid tumor cancers.

In May 2020, Mustang Bio submitted an IND application with the FDA (Food and Drug Administration) to initiate a multi-center Phase 2 clinical trial of MB-107 in newly diagnosed infants with XSCID who are under the age of two. The expectation is that this trial will enroll 10 patients who, together with 15 patients enrolled in the present multicenter trial led by St. Jude Children’s Research Hospital, will be compared with 25 matched historical control patients who have undergone hematopoietic stem cell transplant (HSCT).

Mustang Bio, Inc. (MBIO), closed Tuesday's trading session at $3.18, off by 0.156986%, on 933,043 volume with 3,868 trades. The average volume for the last 3 months is 664,118 and the stock's 52-week low/high is $1.77999997/$4.8499999.

New You, Inc. (NWYU)

CBD Today, Wolf Street, Real Investment Advice, Penny Stock Hub, CIG News (Cannabis Investment Group), Investor Place, FX Empire, Insider Monkey, Wallet Investor, Investors Hangout, Market Screener, OTC.Watch, MarketWatch, PR Newswire, Whale Wisdom, last10k, Tiingo, Business Insider, Barchart, Investing.com, Nasdaq, Dividend Investor, Stockopedia, InvestorsHub, TipRanks, and Stockwatch reported previously on New You, Inc. (NWYU), and today we report on the Company, here at the QualityStocks Daily Newsletter.

New You, Inc. currently holds one subsidiary, NEWYOU LLC. NEWYOU is working to secure a large share of the flourishing U.S. CBD (cannabidiol) market with its flagship product DROPS™. Ray and Daran Grimm, who have successfully built six multi-million dollar companies, founded New You, Inc. The Company markets and sells its products through multi-level marketing and a direct sales force to independent business owners. New You is based in Carlsbad, California. The Company lists on the OTCQB.

New You states that its DROPS nano-CBD uses a proprietary nanoencapsulation technology to deliver superior bioavailability offering more efficacy than traditional CBD oils. The Company offers DROPS, which is a canna-active CBD beverage enhancer; and also offers CB2 & CBD 2 Plus, a multi spectrum hemp-extracted CBD and hops-extracted beta-caryophyllene.

In addition, New You offers Drops for Pets; Caffe Canna, an organic cannabinoid-infused non-GMO dark roast coffee to promote weight loss; and DropsFX Energy, a product to provide the user with an energy boost with a blend of canna-active vitamins B3, B6, B9, and B12. Furthermore, it offers Drops FX Sleep, a product to help users get sleep.

Moreover, the Company’s product family includes The Cream. This is a multi-action 1000 mg CBD cream for inflammation, soreness, as well as being a moisturizer.

New You announced this past March that it has combined three lucrative market trends into one new product with the debut of NEWYOU Caffe Canna™. The debut of Caffe Canna is by New You, Inc.'s NEWYOU subsidiary. NEWYOU Caffe Canna™ is a dark roast instant coffee with two clinically proven weight loss ingredients and Canna-Active™ CBD all in one product. Caffe Canna contains two clinically tested and patented active ingredients, SuperCitrimax® and ChromeMate®.

This month, New You reported that its subsidiary, NEWYOU LLC, officially released NanoX. This is a proprietary 1125 mg Full Spectrum Hemp Complex, the first of its type in the nano CBD space. It is a proprietary formulation and completely water soluble. NanoX contains highly sought after nutritional components. These include liposomal CoQ10, Curcumin, Methyl Vitamin B12, and Colloidal Silver.

New You, Inc. (NWYU), closed Tuesday's trading session at $0.553, even for the day, on 70 volume with 1 trade. The average volume for the last 3 months is 5,083 and the stock's 52-week low/high is $0.150000005/$2.99.

Tonix Pharmaceuticals Holding Corp. (TNXP)

Stock of the Week, BioPharmCatalyst, Zacks, Whale Wisdom, BioPharmaJournal, Invest Chronicle, Investors Welcome, Stocks Newswire, Finbox, Market Screener, InvestorsHub, Investors Observer, DBT News, ETF.com, FX Empire, Stockhouse, MacroTrends, Stocktwits, Proactive Investors, Simply Wall St, TMXmoney, Nasdaq, Morningstar, last10k, GlobeNewswire, and Seeking Alpha reported earlier on Tonix Pharmaceuticals Holding Corp. (TNXP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company listed on the NasdaqGS. It concentrates on discovering, licensing, acquiring, and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. The Company’s portfolio is chiefly composed of central nervous system (CNS) and immunology product candidates. Established in 2007, Tonix Pharmaceuticals is based in New York, New York.

The Company’s Immunology Portfolio includes vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases. The CNS Portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, as well as addiction conditions.

Tonix Pharmaceuticals’ lead vaccine candidate is TNX-1800. It is based on the horsepox viral vector platform to protect against COVID-19, mainly by eliciting a T cell response. The Company expects data from animal studies of TNX-1800 in Q4 of 2020. TNX-801, live horsepox virus vaccine for percutaneous administration, is in development to protect against smallpox and monkeypox. It serves as the vector platform on which TNX-1800 is based.

Tonix Pharmaceuticals’ lead CNS candidate is TNX-102 SL. It is in Phase 3 development for the management of fibromyalgia. Tonix expects results from an unblinded interim analysis in September of this year and topline data in Q4 of 2020. In addition, TNX-102 SL is in development for agitation in Alzheimer’s disease and alcohol use disorder (AUD).

The Company’s programs for treating addiction conditions also include TNX-1300 (T172R/G173Q double-mutant cocaine esterase 200 mg, i.v. solution) that is in Phase 2 development for the treatment of cocaine intoxication and has FDA (Food and Drug Administration) Breakthrough Therapy designation. TNX-601 CR (tianeptine oxalate controlled-release tablets) is another CNS program, now in Phase 1 development as a daytime treatment for depression.

TNX-1900, intranasal oxytocin, is in development as a non-addictive treatment for migraine and cranio-facial pain. Tonix Pharmaceuticals’ preclinical pipeline includes TNX-1600 (triple reuptake inhibitor), TNX-1500 (anti-CD154), and TNX-1700 (rTFF2).

Earlier in June, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include a study of T cell immune responses to SARS-CoV-2 in volunteers who have recovered or remain asymptomatic after exposure to COVID-19. This research is part of a continuing and wider collaboration between Tonix Pharmaceuticals and Southern Research to develop and conduct animal testing of Tonix’s TNX-1800, which is a live replicating virus vaccine designed to protect against COVID-19. The data will support the interpretation of animal trial results with TNX-1800 that are expected in Q4 of 2020 and subsequent human trials.

Yesterday, Tonix Pharmaceuticals announced that because of quicker-than-expected enrollment, it anticipates topline Phase 3 RELIEF results in Q4 of 2020, rather than Q1 of 2021 as earlier guided. RELIEF is a potential pivotal study of TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg, a non-opioid, centrally acting analgesic, taken daily at bedtime for the management of fibromyalgia. An optional interim analysis of the first 50 percent of randomized participants that are evaluable for efficacy will be conducted, with results expected in September of this year.

Tonix Pharmaceuticals Holding Corp. (TNXP), closed Tuesday's trading session at $0.6105, off by 2.0693%, on 5,423,991 volume with 8,972 trades. The average volume for the last 3 months is 7,381,884 and the stock's 52-week low/high is $0.390199989/$14.1000003.

Tonogold Resources, Inc. (TNGL)

Emerging Growth, OTC Dynamics, Morningstar, Wallet Investor, MarketWatch, Proactive Investors, OTC.Watch, YCharts, Stockopedia, OTC Markets, Invezz.com, Seeking Alpha, Market Screener, 24hgold, PR Newswire, Nasdaq, TMXmoney, Baystreet.ca, Simply Wall St, GlobeNewswire, wallstreet:online, travelwirenews, Barchart, InvestorsHub, Agoracom, Trading View, Investors Hangout, Mexico Mining Center, GuruFocus, Cambridge House International, RedCloudfs.com, The Prospector News, Junior Mining Network, Ceo.ca, TipRanks, Stockwatch, and Equities.com reported beforehand on Tonogold Resources, Inc. (TNGL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Tonogold Resources, Inc. operates as a resource/mining company with gold and silver properties in Mexico and the United States. It primarily focuses on assessing options over the Comstock and Mexican gold/silver properties. A foremost junior mining company, Tonogold Resources is headquartered in La Jolla, California. Incorporated in 1997, the Company lists on the OTC Markets.

Tonogold Resources also owns a 100 percent interest in the NevMex iron ore project in Sonora, Mexico. On October 5, 2017, Tonogold announced that it entered into a binding agreement with Comstock Mining, Inc. (NYSE American: LODE) that among other things, provides Tonogold an exclusive right to earn a 51 percent controlling interest in 1,162 acres of mining claims in the highly prospective Comstock Lode region in Virginia City, Nevada, which includes the Lucerne Deposit, located in the Storey and Lyon Counties.

Comstock Mining announced in June of 2019 that Tonogold Resources paid an additional non-refundable cash deposit of $600,000 toward the purchase of Comstock’s Lucerne properties. On January 24, 2019, Comstock Mining entered into an agreement with Tonogold Resources to sell its Lucerne properties for $15 million ($11.5 million in cash and $3.5 million in stock).

Tonogold Resources announced in November of 2019 the Closing of the Comstock acquisition with Comstock Mining. Earlier in 2019, Tonogold Resources and Comstock Mining entered into that agreement wherein Tonogold would acquire a 100 percent interest in the Lucerne project; an exclusive 20-year lease to use, operate, and manage Comstock’s processing facilities, plant, infrastructure and mining claims (called the American Flats Properties); and 100 percent rights to explore, develop, and mine Comstock’s Storey County claims, including those encompassing the significant historic production at Gold Hill and Virginia City (Storey Exploration Claims) for total consideration of $15 million. The Completion of the Storey Exploration Claims took place in September of 2019.

This past April, Tonogold Resources announced several initiatives aimed at enhancing and strengthening the Company in preparation for its initial exploration and evaluation program at the Comstock Lode, Nevada. In December 2019, the Company acquired 100 percent of the rights to explore, develop, and mine certain claims positioned on the world-class, historic Comstock Lode, in Storey County, Nevada. Since that time, Tonogold has moved to considerably strengthen its Board, prepare for an upgrade of its current Pink Sheet listing status, and underpin its medium-term financial position so that funds can now be committed to the first phase drill testing of the Comstock Lode.

The drill program will include 40 holes drilled to an average depth of approximately 250 meters. Together with the earlier acquired Lucerne mine and resource area, Tonogold controls a large, contiguous land position in the historic Comstock district.

Tonogold Resources, Inc. (TNGL), closed Tuesday's trading session at $0.41, off by 1.2048%, on 26,597 volume with 11 trades. The average volume for the last 3 months is 15,835 and the stock's 52-week low/high is $0.151999995/$0.550000011.

Adamera Minerals Corp. (DDNFF)

Penny Stock Hub, All Stocks Today, TheNewswire, Investing News, Emerging Growth, Dividend Investor, Morningstar, Stockhouse, OTC Markets, Northern Miner, Gold Stock Data, Macroaxis, Wallet Investor, TeleTrader, Mining Stock Education, Street Insider, Investors Hangout, Uptick Newswire, Resource World, and Junior Mining Network reported beforehand on Adamera Minerals Corp. (DDNFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Adamera Minerals Corp. is a junior exploration company based in Vancouver, British Columbia. It is exploring for high-grade gold deposits in the well-established mining district of northeastern Washington State. Currently, the Company is drilling several targets in the Cooke Mountain district. Adamera Minerals’ shares trade on the OTC Markets.

The northeastern Washington State area has produced greater than 6,000,000 oz of gold historically. Adamera Minerals is exploring a number of highly prospective projects. It is the most dominant regional exploration company. This region also has the Kettle River Mill on Care and Maintenance that is depleted of ore, which could be strategically beneficial.

Adamera Minerals holds an extensive land position in the Cooke Mountain region in Washington State. The land surrounds or includes part of 5 past producing mines. These include Overlook, Lamefoot, Key West, Key East and Belcher. The Kettle River Gold Mill is central to Adamera’s Cooke Mountain project.

The Empire Creek property is on the western margin of the Republic Graben. It is 6km south of the K2 Mine that produced over 1 million ounces of gold and 15km north of the Republic gold district that hosts 3M oz. @ 20g/t Au and 16M oz. @ 110g/t Ag.

The Talisman Historic Copper-Silver Mine is about 95 kilometers by major highway from the Teck Trail Smelter. Samples from the initial program yielded mineralization as high as 144 g/t silver, 3.45% copper, 6.3% lead and 6.91% zinc. A recently completed magnetic survey defined a large magnetic high anomaly west of the mine that appears to be associated with this mineralization.

The Flag Hill Mine Property is on BLM (Bureau of Land Management) land within the Republic Gold Mine district, 1 km from the Eureka trend where more than 2.8 million ounces of gold (average grade 20g/t) and 15.8 million ounces of silver (average grade 110 g/t) were recovered. This property is 10 kilometers from the Kettle River Mill.

Recently, Adamera Minerals announced that it entered into an option/joint venture (JV) agreement with Hochschild Mining (US) Inc., a wholly-owned subsidiary of Hochschild Mining PLC (LSE:HOC) on its Cooke Mountain gold project in Washington State. Hochschild is a foremost underground precious metals producer centered on high-grade silver and gold deposits. Hochschild has more than 50 years’ operating experience in the Americas. It is well suited to explore and develop Adamera Minerals’ numerous high-grade gold targets at Cooke Mountain.

Adamera Minerals has retained 100 percent ownership of the Flag Hill and Empire Creek gold projects. With Hochschild sole funding the Cooke Mountain project for the foreseeable future, Adamera’s intention is to bring attention to these opportunities in 2020.

Adamera Minerals Corp. (DDNFF), closed Tuesday's trading session at $0.065, up 35.4167%, on 398,500 volume with 40 trades. The average volume for the last 3 months is 57,990 and the stock's 52-week low/high is $0.010999999/$0.064999997.

Horizons Holdings International, Corp. (HZHI)

All Penny Stocks, Stock Scores, All Stocks Today, EquityNet.com, OTC Markets, TipRanks, Market Wire News, Stockhouse, MarketWatch, PRWeb, InvestorsHub, Morningstar, Dividend.com, GuruFocus, Seeking Alpha, TradingView, Wallet Investor, Dividend Investor, Stockwatch, Market Screener, and PR Newswire reported earlier on Horizons Holdings International, Corp. (HZHI), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Horizons Holdings International, Corp. operates as a holding, development and investment company. Its purpose is to enable the acquisition of existing companies and provide additional capital and expertise to boost revenue and profitability of the acquired companies. The Company previously went by the name Horizon Health International Corp. It changed its name to Horizons Holdings International, Corp. in April of 2015. The Company lists on the OTC Markets and is headquartered in Las Vegas, Nevada.

Horizons Holdings International works to maintain an inventory of premier investment opportunities. At present, its emphasis is on the development of its wholly owned subsidiary, Pai-Tech. Pai-Tech has developed a brand-new Bot Operating System Standard (B.O.S.S.). It provides a digital workforce of intelligent and intuitive bots. PAI-BOSS provides a distributed operating system powered by PAI-BOTS. These run advanced AI (Artificial Intelligence) algorithms and offer real-time, autonomous, and also distributed solutions.

Pai’s intelligent bots are able to work in any sector and industry. They provide businesses increased levels of cybersecurity and save companies valuable time and money through decreasing workforce costs, avoiding human errors, increasing the quality of work and enabling data to be read in real-time. Furthermore, Pai’s system is a 24/7 operation, is quantum safe, offers customizable scalable solutions, and has a short payback (ROI) period.

In September, Horizons Holdings International confirmed that its subsidiary, Pai-Tech Artificial Intelligence Ltd., signed an OEM (original equipment manufacturer) distribution agreement with Real Time ltd. to develop and distribute products based on PAI's Bot Operating System Standard (PAI-BOSS). Real Time has already developed a distributed and automated solution for the HR field, HR-BOT. It has been installed in the Israeli government and is going to be sold internationally to enterprise corporations and governments.

Pai-Tech Artificial Intelligence has developed a portfolio of Intellectual Property (IP) and has filed a number of patents to the USPTO (United States Patent and Trademark Office). Pai-Tech makes computers smarter via the power of intelligent bots. The company is pioneering computer software with the development of the world's first Bot Operating System Standard (B.O.S.S.).

Earlier in October, Horizons Holdings International disclosed that its subsidiary, Pai-Tech Artificial Intelligence, co-led the technical development with The Floor for their proprietary Idea Generation Engine called the Discovery platform. The Discovery platform was developed benefiting from Pai-Tech's distributed Operating System (PAI-BOSS).

PAI-BOSS provides the ability to distribute data for better security, distribute workload for better performance, and provides a distributed network architecture to ensure data isolation and protection for each user. The Discovery platform is one of The Floor's proprietary tools for empowering tier-1 banks throughout their digital transformation. The Floor's exclusive ecosystem of Banking Partners has benefited from faster technology adoption and access to market-leading solutions.

Horizons Holdings International, Corp. (HZHI), closed Tuesday's trading session at $0.0999, up 99.80%, on 1,001 volume with 1 trade. The average volume for the last 3 months is 3,913 and the stock's 52-week low/high is $0.029999999/$2.45000004.

Adynxx, Inc. (ADYX)

TipRanks, TMXmoney, Xconomy, Street Insider, Investing.com, BioCentury, Stockhouse, Market Screener, TradingView, Stockopedia, Dividend Investor, GlobeNewswire, and PR Newswire reported previously on Adynxx, Inc. (ADYX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A clinical stage biopharmaceutical company, Adynxx, Inc. focuses on bringing to market novel, disease-modifying products for the treatment of pain and inflammation. The Company’s pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including inflammatory and neuropathic pain. Fundamentally, Adynxx is a leader in transcription factor decoy technology. Established in 2007, Adynxx has its corporate headquarters in San Francisco, California.

The Company has worked since its founding to discover and develop transcription factor decoys to modify the course of pain, to collaborate with discovery partners, and to identify in-licensing opportunities with transformative therapeutic profiles to build a pipeline in pain and inflammation.

Adynxx is collaborating with twoXAR to use twoXAR’s artificial intelligence-driven drug discovery platform. This is to identify endometriosis treatments. In addition, Adynxx is evaluating in-licensing opportunities with transformative therapeutic profiles to treat pain and inflammation.

The AYX platform employs a proprietary technology of non-opioid, disease-modifying transcription factor decoys. AYX decoys are short DNA molecules, or oligonucleotides. They selectively inhibit transcription factors controlling the genes involved in the maintenance of pain. Therefore, a single administration of an AYX decoy generates a strong, long-term reduction of pain and associated clinical benefits.

Clinical studies suggest that a single administration of brivoligide at the time of surgery can safely lessen pain for weeks, speed up the time to attain mild pain and considerably decrease the need for opioid use during recovery specifically in patients at greater risk of experiencing increased and prolonged pain following surgery.

Recently, Adynxx announced that Mr. Gregory J. Flesher, Chief Executive Officer (CEO) at Novus Therapeutics, Inc. (NASDAQ: NVUS), was appointed to the Adynxx Board of Directors. Since May of 2017, Mr. Flesher has served as the CEO and a member of the Board of Directors of Novus Therapeutics, a specialty pharmaceutical company centered on developing products for patients with disorders of the ear, nose and throat.

For Q2 of 2019, Adynxx reported a Net Loss of $4.7 million, versus a Net Loss of $1.4 million for the same period in 2018. Research and development expenses were $1.9 million in Q2 of 2019, versus $0.6 million for the same period in 2018. This increase was mainly because of $0.7 million in connection with start-up activities related to Adynxx's planned Phase 2 ADYX-005 total knee arthroplasty and Phase 2 ADYX-006 mastectomy clinical trials and $0.7 million related to the initiation of drug supply manufacturing with Avecia, partially offset by a decrease in salaries and benefits from the resignation of an employee and other minor cost changes.

Adynxx, Inc. (ADYX), closed Tuesday's trading session at $0.62, up 40.8771%, on 15,980 volume with 30 trades. The average volume for the last 3 months is 828 and the stock's 52-week low/high is $0.310099989/$3.53999996.

Dajin Resources Corp. (DJIFF)

StreetWise Reports, Penny Stock Tweets, GoldTelegraph, The Prospector News, 24hgold, Metals News, Investing News, Junior Mining Network, BullMarketNews, 4-Traders, Mining Feeds, StockInvest, Simply Wall St, and OTC Markets reported earlier on Dajin Resources Corp. (DJIFF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Dajin Resources Corp., together with its subsidiaries, mainly engages in the acquisition, exploration, and development of mineral properties in Canada, the United States, and Argentina. An early stage Lithium brine exploration company, Dajin, via its interest in Dajin Resources S.A. (Dajin S.A.), holds concessions or concession applications in Jujuy Province, Argentina, which were acquired in areas known to contain brines with Lithium, Potassium and Boron values. Dajin Resources has its corporate headquarters in Vancouver, British Columbia.

The land holdings in Jujuy Province, Argentina exceed 93,000 hectares (230,000 acres). They are chiefly situated in the Salinas Grandes and Guayatayoc salt lake basins. Dajin S.A. is partnered with Pluspetrol Resources Corporation B.V. - as operator is required to spend $2,000,000 to earn a 51 percent interest in Dajin S.A. Lithium properties.

The Phase One exploration program of the 4,400 hectares (10,873 acres) in San Jose-Navidad minas has completed the program where 25 shallow brine samples were taken. The assays returned Lithium brine concentrations ranging from 281 mg/l to 1,353 mg/l averaging 591 mg/l.

In addition, Dajin holds a 100 percent interest in 403 placer claims encompassing 7,914 acres (3,202 hectares) in the Teels Marsh valley of Mineral County, Nevada. These claims are known to contain Lithium and Boron values. They are next to the birth place of US Borax Corp's first borax mine.

Furthermore, Dajin holds a 100 percent interest in 145 placer claims encompassing 2,921 acres (1,182 hectares) in the Alkali Spring valley (also called Alkali Lake valley) of Esmeralda County, Nevada, positioned 7 miles (11 kilometers) northeast of Albemarle's Silver Peak Lithium brine operation in Clayton Valley.

In November of 2018, Dajin Resources announced the signing of a Definitive Agreement with Cypress Development Corp. (TSX-V: CYP) (OTCQB: CYDVF) for the exploration and development of Dajin Resources’ Alkali Spring valley Lithium property in Esmeralda County, Nevada. This property is 12 kilometers (7.5 miles) northeast of Cypress Development’s Clayton Valley Lithium project in Nevada. With this Agreement, Cypress will have the exclusive right and option to acquire a 50 percent undivided interest in Dajin Resources’ unpatented placer mining claims and application for water rights in Alkali Spring valley, Esmeralda County.

Recently, Dajin Resources reported that Pluspetrol Resources Corporation B.V. acquired 100 percent of the issued and outstanding common shares of LSC Lithium Corporation (LSC) for a cash consideration of about CDN $111 million. Dajin was partnered with LSC who has, by way of its wholly-owned subsidiary Lithium S Holding Corporation, an earn-in agreement to spend CDN $2,000,000 to earn a 51 percent interest in Dajin Resources S.A. Pluspetrol has created the company Litica Resources S.A. for exploration and development of its concessions.

Dajin Resources Corp. (DJIFF), closed Tuesday's trading session at $0.0387, up 35.7895%, on 460,145 volume with 47 trades. The average volume for the last 3 months is 72,915 and the stock's 52-week low/high is $0.007799999/$0.038699999.

Fortem Resources, Inc. (FTMR)

Stock Target Advisor, StockScores, Stock Alert, Marketbeat, OTC Markets, Teletrader, Private Capital Newswire, Infront Analytics, Real Investment Advice, Market Screener, Stockwatch, MarketWatch, InvestorsHub, and Stockhouse reported previously on Fortem Resources, Inc. (FTMR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Fortem Resources, Inc. is an oil and gas corporation that holds properties in Alberta and Utah. It engages in the exploration, development and production of crude oil and natural gas in the Western Canadian Sedimentary Basin and Utah in the United States. Fortem Resources has its Calgary, Alberta operations office and its North Orem, Utah operations office.

A diversified natural resource enterprise, the Company is seeking North American and global expansion via an acquisition strategy. Fortem seeks out, evaluates and acquires working interests (WIs) in oil and gas and other resource projects in North America and worldwide. Its strategy remains centered on developing quality energy projects with lower risk profiles and identified upside potential.

The Company holds five wholly-owned subsidiaries named Rolling Rock Resources, Black Dragon Energy, Colony Energy, Big Lake Energy and City of Gold. Withstanding City of Gold, the remaining four companies hold greater than 350,000 acres of prolific oil and gas fields, with proven reserves, production and future development for 2019.

Fortem Resources has come across a rare global gold mining asset in Myanmar, South Asia. With 465 square kilometers of mining area, City of Gold has the potential of unlocking one of the largest gold mines in the world. Fortem has appointed a highly qualified team with more than three decades in the minerals industry.

Fortem Resources is concentrating on optimizing its present assets to enhance Company value. It continues to increase its asset base on acquisitions, farm-ins, joint ventures (JVs) and land sale purchases. It is targeting high WI opportunities with year-round access, strong growth, and economic potential in proven oil and gas areas throughout the world. Moreover, it is searching for regions with low geological risk and the potential for high netback revenues.

Recently, Fortem Resources announced that it is in the process of starting field operations via its wholly-owned subsidiary Colony Energy, LLC at its Godin Property in north central Alberta. Colony has the rights to an undivided 100 percent WI in a total of 80 contiguous sections (51,200 acres) in addition to its 20 contiguous sections (12,800 acres) of heavy oil leases in north central Alberta. Colony Energy has prepared tenders. It is seeking bids from different service companies to put its first well on its Godin property in production.

Fortem Resources, Inc. (FTMR), closed Tuesday's trading session at $0.80, up 46.1187%, on 26,701 volume with 19 trades. The average volume for the last 3 months is 6,620 and the stock's 52-week low/high is $0.270700007/$2.24.

Anvia Holdings Corporation (ANVV)

Stock Target Advisor, GlobeNewswire, MarketWatch, Barchart, Simply Wall St, GuruFocus, Stockhouse, Trading View, Market Screener, Last10k, Stockwatch, Wallet Investor, Dividend Investor, and InvestorsHub reported beforehand on Anvia Holdings Corporation (ANVV), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Anvia Holdings Corporation is an international technology for self and business improvement company. It has acquired and developed a number of proprietary software, mobile applications, learning and educational tools to help consumers and businesses improve and grow. The Company’s mission is to make personal and business growth accessible and sustainable.

The Company was previously known as Dove Street Acquisition Corporation. It changed its name to Anvia Holdings Corporation in January of 2017. Founded in 2016, Anvia Holdings is headquartered in Glendale, California.

The Anvia business and organizational portfolio comprises software and mobile application technologies, consulting services, coaching services, and blended learning content and activities. Some of the areas it serves its business clients are Strategy Management, Competency Management, Performance Management, Learning Management, Customer Experience Management, Franchise, Corporate Advisory and Listing, and HR Information Systems.

Recently, Anvia Holdings announced that it executed a definitive agreement to acquire all of the issued and outstanding shares of XSEED Pty Ltd, an Australian Registered Training Organization. With this agreement, Anvia Holdings, via its fully-owned subsidiary Anvia (Australia) Pty Ltd shall acquire 100 percent of XSEED Pty Ltd outstanding shares for approximately USD 352,000 (AUD 500,000). XSEED engages in the provision of vocational education training (VET) and offers courses that are for the Automotive and Hairdressing industries.

Anvia (Australia) Pty Ltd Chief Executive Officer, Mr. James Kennett, said “Adding XSEED to our education services portfolio solidifies our position in Australia as a major player in Education Services. In addition, XSEED will diversify our current CRICOS and Corporate learning income with further revenue sources.”

Anvia Holdings also recently announced it filed an application to list its common shares on the NASDAQ Capital Market.

Ali Kasa, Chief Executive Officer and President of Anvia Holdings, said, “The listing of our common shares on NASDAQ would reflect the progress we are making to strengthening our corporate governance and mark another significant milestone in our quest to become a global leader in the self and business improvement industry.”

Anvia Holdings Corporation (ANVV), closed Tuesday's trading session at $0.04, up 300.00%, on 647 volume. The average volume for the last 3 months is 26 and the stock's 52-week low/high is $0.019999999/$6.00.

Towerstream Corp. (TWER)

MadPennyStocks, MarketClub Analysis, Money Morning, PennyOmega, OTCBB Journal, OTCMagic, Penny Picks, KingPennyStocks, BUYINS.NET, Damn Good Penny Picks, Penny Stock Prodigy, CoolPennyStocks, Epic Stock Picks, Hit and Run Candle Sticks, HotOTC, Investing Futures, MicroCapDaily, Investment Contrarians, Jason Bond, Broad Street, BullRally, PennyInvest, and ChartPoppers reported on Towerstream Corp. (TWER), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Towerstream Corp. is a leading Fixed-Wireless Fiber Alternative business.  The Company delivers high-speed Internet access to businesses. Together with its subsidiaries, it provides fixed wireless broadband services and delivers access over a wireless network transmitting over regulated and unregulated radio spectrum to commercial customers in the United States. Towerstream has its corporate office in Middletown, Rhode Island.

Towerstream announced earlier in 2018 that its Board of Directors started evaluation of strategic repositioning of the Company as it moves to take advantage of its existing important assets in major American markets. In association with the announcement, Towerstream launched a determined focus on indirect and wholesale channels and the retention of Bank Street Group LLC as its independent financial advisor to explore strategic alternatives with such broadband carriers.

Towerstream provides broadband services in twelve urban markets. These include New York City, Boston, Los Angeles, Chicago, Philadelphia, the San Francisco Bay area, Miami, Seattle, Dallas-Fort Worth, Houston, Las Vegas-Reno, and the greater Providence area.  Towerstream has constructed 175 Major Points of Presence (POPs). The Company positions its POPs on the tops of buildings.

Towerstream is a last-mile facilities-based provider. It owns its entire network. The Company totally bypasses the local exchange carrier and cable providers. Its solution to businesses either complements or replaces existing Internet connections. Towerstream provides property managers, building owners, and their commercial tenants a redundant and reliable dense urban network. This network directly connects to the Company’s fiber backbone. 

Towerstream has its Single Tenant Internet Solution. This solution is for customers not in On-Net buildings. The Single Tenant Internet Solution provides primary and back-up dedicated internet access as a faster and less expensive alternative to fiber. On-Net refers to the extensive number of buildings in Towerstream’s 12 coverage markets now lit for On-Net Business Internet Service. The Company’s On-Net Service provides businesses within its continually growing portfolio of On-Net buildings with dedicated and symmetrical Internet connectivity.

Towerstream Fixed Wireless features fast installation, guaranteed 99.99 percent uptime backed by the Company’s industry leading SLA, and scalability. It also features faster than fiber, true redundancy, and symmetrical speeds.

Towerstream Corp. (TWER), closed Tuesday's trading session at $0.90, up 200.00%, on 1,307 volume with 5 trades. The average volume for the last 3 months is 642 and the stock's 52-week low/high is $0.200000002/$2.00.

The QualityStocks Company Corner

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B)

The QualityStocks Daily Newsletter would like to spotlight Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B).

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) today announced gold and silver assay results from nine more of the 25 holes recently drilled at its Bullfrog Project (“Project”). Among key highlights, the update reads, “Drilling continued to intercept thick intervals of gold mineralization in the Mystery Hill (MH) deposit. BH 20-6 intersected 110 meters averaging 0.41 g gold/t, including 26 meters of 0.91 g/t. BH-20-9 intersected 91 meters averaging 0.33 g/t and an upper interval of 6 meters averaging 0.53 at 23 meters. Most of the new intercepts are not in areas previously included in measured and indicated resource classifications.” To view the full press release, visit http://nnw.fm/YX2fG

Bullfrog Gold Corp. (the “Company”) (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) is a Delaware corporation engaged in the acquisition, exploration and development of gold and silver properties in the United States. The Company controls strategic lands with established 43-101 compliant resources in one of the most exciting gold exploration areas in the United States. The Bullfrog Gold Project (“Project”) includes a lease/option on much of the lands where Barrick Bullfrog Inc., a subsidiary of Barrick Gold Corp., produced more than 2.3 million ounces of gold and 2.49 million ounces of silver from 1989 to 1999. The Project is located within the prolific Walker Trend about 125 miles northwest of Las Vegas, Nevada.

Project Highlights

  • The Company initially acquired 79 unpatented claims and two patents in mid-2011 and has since staked, leased, optioned, or purchased lands that now total 5,250 acres. Via a 2015 lease/option with Barrick, the Project includes the northern one-third of the Bullfrog deposit where most of the current resources in the Bullfrog mine area occur, along with their interest in the Montgomery-Shoshone deposit which gave the Company 100% control.
  • In mid-2017, a NI 43-101-compliant report by independent mining consultancy Tetra Tech Inc. estimated measured and indicated (“M&I”) resources of 624,000 ounces of gold and 1.73 million ounces of silver at average grades of 0.70 g/t and 1.93 g/t, respectively. The expansion plans of these two pits were based on a $1200 gold price, use of heap leach processing, and also included 110,000 ounces of inferred gold resources averaging 1.20 g/t. Barrick used conventional milling to process an average gold grade of 3 g/t.
  • The established resources and exploration potential of the Project are strongly supported by a large data base obtained from Barrick, including detailed information on 155 miles of drilling in 1,262 holes in the Bullfrog mine area.

Gold Rush in the Bullfrog Territory

The area around Beatty, Nevada has now attracted AngloGold Ashanti, Kinross Gold, Corvus Gold, Coeur Mining as well as the Company and Waterton. In this regard, Northern Empire Resources Corp’s property located a few miles east of the Project was acquired by Coeur Mining in October 2018 for C$117 million, implying a valuation of C$134/oz of inferred resources. As of today, the Company is trading at a significant discount to the valuation at which Northern Empire was purchased (http://nnw.fm/9NaaN), thereby highlighting the Company’s value proposition for investors.

Bullfrog Gold Corp. is focused on enhancing shareholder returns by concurrently advancing Project development and performing exploration drilling programs on several targets identified by the Company.

Secured Financing for 2020 Operations

Bullfrog Gold Corp. raised C$2 million in January 2020 through a private placement of shares priced at C$0.13/share plus a one-half warrant exercisable within two years at C$0.20 on a full warrant basis. The raise was carried out primarily to fund a drill program that started on May 1 (http://nnw.fm/6nZ0m), and was completed on June 6, 2020. Results from drilling 12,520 feet in 25 holes will be released in the coming weeks. The Company subsequently intends to conduct a preliminary financial analysis and complete further drill programs to advance the Project and add value. The financing was subscribed by several influential shareholders, including a former director of Northern Empire, who handled the sale of the company to Coeur Mining, and Eros Resources, the management of which has been involved with several high-profile mining projects and sales in the past.

Gold Prices estimated to average $1,800/oz in 2021

Gold prices have been on a remarkable run in 2020, rising by $245/oz to $1,760 prior to peaking in early May. Global central banks carried out 144 interest rate cuts thus far in 2020, reducing their rates by a cumulative 5,035 basis points (http://nnw.fm/jzZt0). Meanwhile, the IMF has estimated that global governments have introduced fiscal support measures amounting to over $9 trillion since the start of the COVID-19 pandemic (http://nnw.fm/Or9rI). The resulting weakness in the U.S. dollar and eventual inflationary pressures stemming from these measures prompted Credit Suisse to recently hike their gold price forecasts for the full year to $1,701/oz (from $1,570 previously), while the outlook for 2021 has been raised to $1,800/oz (versus $1,600 previously) (http://nnw.fm/Iqg0X).

Management Team

David Beling, CEO, President and Director
David Beling is a Registered Professional Mining Engineer with 55 years of diverse experience in areas such as engineering, development, permitting, construction, financing and management of mines and plants and the building and growth of several corporations. His initial employment included 14 years with Phelps Dodge, Union Oil, Fluor, United Technologies, and Westinghouse, followed by 41 years of senior management and consulting with 25+ U.S. and Canadian mining companies. In 2006-2007, he spearheaded an IPO, successfully drove equity raises totaling C$112 million and grew that Company’s market capitalization to $460 million. Beling has served on 14 boards since 1981, including three mining companies distinguished by the TSX Venture Exchange as top-10 performers.

Alan Lindsay, Chairman of the Board
Alan Lindsay is an entrepreneur and businessman who has founded seven companies within the mining and pharmaceutical industries, including Anatolia Minerals Development Ltd., Uranium Energy Corp., Oroperu Mineral, Strategic American Oil and AZCO Mining. Lindsay also developed the strategic vision for the 2011 acquisition and placement of the Project from NPX Metals into Bullfrog Gold Corp.

Kjeld Thygesen, Director
Kjeld is a graduate of the University of Natal in South Africa and has 48 years of experience as a resource analyst and fund manager. In 1972, he joined James Capel and Co. in London as part of its highly rated gold and mining research team before subsequently becoming manager of N. M. Rothschild & Sons’ commodities and Natural Resources Department in 1979. In 1987, he became an executive director of N. M. Rothschild International Asset Management Ltd., before co-founding Lion Resource Management Ltd., a specialist investment manager in the mining and natural resources sector, in 1989. Thygesen has been a director of Ivanhoe Mines Ltd. since 2001 and served as investment director for Resources Investment Trust PLC from 2002 to 2006.

Tyler Minnick, CFO and Director of Administration & Finance
A registered member of the Colorado Society of Certified Public Accountants with over 24 years of experience within the fields of accounting, auditing, and administrative services. Minnick has been engaged with the Company since mid-2011 and previously worked in the finance department of MDC Holdings/Richmond American Homes, one of the largest residential construction companies in the United States.

Bullfrog Gold Corp. (OTCQB: BFGC), closed Tuesday's trading session at $0.17625, up 30.5556%, on 629,816 volume with 94 trades. The average volume for the last 3 months is 110,684 and the stock's 52-week low/high is $0.047449998/$0.180000007.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

As the nation’s economy slammed shut due to the pandemic, certain sectors seemed to defy the severity of the situation. The digital world seemed to defy gravity, generating ever more interest and expediting uptake out of necessity. A recent press release from SRAX Inc. (NASDAQ: SRAX) (SRAX Profile) is a prime example of such gravity-defying action and may be a harbinger of what’s to come. 

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Tuesday's trading session at $2.54, up 1.60%, on 111,304 volume with 481 trades. The average volume for the last 3 months is 61,573 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries, today announced its entry into a worldwide co-marketing agreement with German-based Leica Microsystems CMS GmbH, a Danaher company. Per the update, the historic alliance is expected to offer transformative new empowerment to cancer research worldwide through integrating the latest enabling technologies in capturing, isolating and preparing biopsy samples for superior analysis of relevant biomarkers of disease state and treatment response. To view the full press release, visit http://nnw.fm/38KYp

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Tuesday's trading session at $2.295, off by 5.5556%, on 30,981 volume with 70 trades. The average volume for the last 3 months is 16,695 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Monday announced the closing of its previously announced transaction. According to the update, Predictive Oncology secured approximately $2.2 million in gross cash proceeds from the transaction, prior to deducting placement agent fees and offering expenses, through the exercise of certain existing warrants by several holders to purchase an aggregate of up to 1,396,826 shares of common stock, each at an exercise price of $1.575. To view the full press release, visit http://nnw.fm/0SJ0o

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Tuesday's trading session at $1.64, off by 4.0936%, on 577,635 volume with 1,680 trades. The average volume for the last 3 months is 980,200 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

ISW Holdings (ISWH)

The QualityStocks Daily Newsletter would like to spotlight ISW Holdings (ISWH).

ISW Holdings (OTC: ISWH), a global brand management holdings company, today announced that the Financial Industry Regulatory Authority, Inc. (“FINRA”) has approved the Company’s official name change to “ISW Holdings, Inc.” (from “International Spirits & Wellness Holdings, Inc.”). To view the full press release, visit http://ccw.fm/Vpco7

ISW Holdings (ISWH) (“ISW Holdings”) is a brand management portfolio company with diverse partnerships that focus on growing businesses in multiple sectors, including crypto mining, renewable energy, home health care for the chronically ill, wellness and restoration, and the adult beverage industry, as well as early-stage operations in supply chain and logistics management. ISW Holdings operates as the nexus between its partnerships and their essential services for end users.

Mission
The company’s core mission is to enhance these sectors by implementing innovative services and products ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources, and innovative software to establish market-leading companies and partnerships, which ensure their success in their chosen industries. This enables the company to return maximum shareholder value with its focus always on its partnerships’ various sector volatility.

The Revolution
Positioned to create industry leaders, the company’s process entails strategic development and aggressive early growth of its partner brands to establish them as profitable and viable. ISW Holdings’ method is to nurture emerging partner brands through the essential stages of market development (from conceptualization to distribution) in sectors relevant to today’s marketplace. In addition, the company has a holistic approach to business development, with every strategy being delivered person-to-person from developers to end users.

The Challenge
The company’s goal is to turn its target audience into loyal consumers by ensuring transparency and a clear understanding of its products and services, thus creating visibility, credibility, and trust.

ISW Holdings’ Innovative Approach
ISW Holdings has diversified positions in its partnerships across technology, health care, wellness, renewable energy, and the adult beverage sectors. The company seek to provide industry leading modern solutions to its clients and sound business practices to its partners. This is accomplished through an early growth platform that cultivates its partnerships with the necessary resources and expertise to expand exponentially.

ISW Holdings’ Opportunity
The company’s opportunity is considerable. In the ever-changing high demand global marketplace, the need for timely innovation is critical. ISW Holdings’ portfolio brand management and creative thinking has allowed the company to develop and deploy enterprises that meet the needs of 21st century consumers. Through a fully vetted system of scalability, it is able to meet consumer demands with turn-key solutions.

Portfolio of Partnerships and Businesses
ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. With partnerships that incorporate a depth of experience and industry insight, ISW Holdings has established itself as a portfolio company in technology, home health care, and wellness, with a focus on reshaping industry benchmarks.

Bit5ive

ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. As an official distribution partner of Bitmain (the industry’s leading fabless manufacturer of computing chips and distributor of Antminers to more than 30 countries in Latin America, Central America, and the Caribbean), Bit5ive is quickly becoming one of the largest U.S.-based companies in the cryptocurrency mining and bitcoin farm sectors of the market.
Valued at $293.66 million in 2019, the bitcoin technology market is expected to reach $477 million by 2025, according to Mordor Intelligence. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.

Proceso, LLC

With a growing awareness of the importance of renewable energy worldwide, ISW Holdings has partnered with Proceso, LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining – two fields with a typically high energy demand.

Because crypto mining companies mostly operate outside of the United States with higher asset security risks, Proceso will assist these entities in securing their investments by providing a local source of power and infrastructure development. This is aimed at helping to reduce power consumption while creating secure crypto mining data centers in the U.S. For the gaming industry, Proceso is ready to tackle one of its biggest problems, latency, by building next-level infrastructure in key locations.

PHH – Home Health

PHH Paradigm Home Health answers the growing need for homecare services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care. PHH aims to be at the forefront of this change by offering quality care services infused with new emerging technologies.

ISW Holdings’ home health division is currently developing a pilot for on-demand health care, which consists of a dedicated, stable platform for different medical services. The platform will offer greater freedom of choice and transparency by allowing users to find outpatient clinics in their vicinities, compare costs, and pick the most suitable choices. PHH is also developing specialized technology and tools to support health care services outside of the bounds of specialized facilities by focusing on homecare facilities. This can not only shift the burden from hospitals and clinics, but also streamline specific parts of the health care process to enhance service and product distribution.

VOLUM

ISW Holdings’ logistics and supply chain management division was designed with the core goal of increasing supply chain efficiency as one of the key aspects of successfully growing any business. The VOLUM project’s focus is on identifying and then implementing advanced supply chain management strategies and methods that will enable ISW Holdings’ partner companies to scale and grow exponentially. To achieve this goal, the company develops and offers reliable systems and solutions that create innovative technologies and unmanned system operations for overall higher cost-effectiveness.

In the wellness sector, ISW Holdings has opted for a two-pronged approach to create effective, technologically advanced products, as well as developing innovative ways to educate customers about these products. To this end, ISW Holdings has partnered with BioPulse to achieve state-of-the-art research and development and production capabilities, as well as a direct route to market. The company plans to design and launch up to five unique brands in the wellness and restoration sector in 2020.

ISW Holdings is committed to developing product and service innovation in the consumer spirits and adult beverage industry, which faces increasingly strict regulations but growing demand. The company has been a key innovator in the industry for 25 years, having grown successful luxury brands such as Besado Tequila and others. By leveraging its expertise, ISW Holdings can help companies in the adult beverage industry increase production, streamline their supply chains, implement better processes, innovate their marketing strategies, expand into new areas, and build sustainable relationships with partners and customers.

Management Team

Terry Williams, Chief Executive Officer and Director
Terry Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance, and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, Williams amassed considerable corporate experience at United Parcel Service, where he took several logistical roles, including controller, where he managed more than 2,000 employees and a budget of more than $10 billion.

Williams also serves as president of Airwave Transportation and logistics and chief financial officer of AVI Insurance Caribbean, and he has worked in over 37 domestic and international airports. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce, Chairman
Alonzo Pierce is chairman of ISW Holdings and brings a wealth of business development and wealth management experience to the ISW team. He has spent the past 20 years building recognizable brands in multiple industry sectors. He has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands, including selling the world’s only black vodka. He served as regional director for Sapphire Brands, covering the Southwest and Southeast regions. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown, Secretary, Treasurer, Director
Kristina Mahoney-Brown is secretary and treasurer as well as director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

ISW Holdings (ISWH), closed Tuesday's trading session at $0.235, off by 38.1579%, on 329,005 volume with 98 trades. The average volume for the last 3 months is 12,623 and the stock's 52-week low/high is $0.109999999/$8.50.

Recent News

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA), the company that developed and launched a cloud-based platform that lets people buy and sell vehicles with never-seen-before speed, simplicity, and cost-efficiency, is preparing to release its Driveway consumer app across the United States. The app will be integrated with PowerBand’s innovative virtual transaction platform and will allow consumers to sell, buy and trade vehicles from their smart phones and other devices regardless of location (http://nnw.fm/2Xdy6). Also today, the company announced that its CEO, Kelly Jennings, has been featured in an exclusive audio interview with NetworkNewsWire (“NNW”), a financial news and content distribution company and one of 45+ brands in the InvestorBrandNetwork (“IBN”). During the interview, Jennings discussed his automotive industry experience, as well as PowerBand’s ongoing efforts to simplify and modernize car buying for consumers. To view the full press release, visit http://nnw.fm/z5BVc

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Tuesday's trading session at $0.1894, off by 3.0706%, on 39,093 volume with 30 trades. The average volume for the last 3 months is 76,326 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Despite unusual events creating an uncertain economic landscape, 2020 is proving to be a successful year so far for SinglePoint (OTCQB: SING), a diversified holdings company with operations in several high-performance market sectors. With impressive results coming from both their 1606 Hemp and Direct Solar subsidiaries, SING continues to successfully propel its business model forward by acquiring significant stakes in businesses and then fast-tracking their growth with operations, development, and management expertise.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Tuesday's trading session at $0.00505, off by 0.980392%, on 2,042,474 volume with 78 trades. The average volume for the last 3 months is 5,079,529 and the stock's 52-week low/high is $0.004/$0.019999999.

Recent News

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (SGMD) was featured today in the 420 with CNW by CannabisNewsWire. A lot is being learned about the intersection between consuming marijuana and diabetes. Recently, a team of researchers has revealed that lots of people may be prone to developing diabetes after suffering from the severe forms of the COVID-19 disease. This complication can be alleviated using cannabis, the researchers think.

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Tuesday's trading session at $0.0042, off by 12.50%, on 116,748,832 volume with 924 trades. The average volume for the last 3 months is 45,783,079 and the stock's 52-week low/high is $0.001599999/$0.030999999.

Recent News

Wrap Technologies Inc. (NASDAQ: WRTC)

The QualityStocks Daily Newsletter would like to spotlight Wrap Technologies Inc. (NASDAQ: WRTC).

Wrap Technologies Inc. (NASDAQ: WRTC) was highlighted today in a report by NetworkNewsWire explaining how, despite lockdowns, creative data analytics and digital marketing deliver incredible results.

Wrap Technologies Inc. (NASDAQ: WRTC) is an innovator of modern policing solutions. The company’s BolaWrap® product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar® tether to restrain an individual at a range of 10-25 feet. Developed by award-winning inventor Elwood Norris, the company’s chief technology officer, the small-but-powerful BolaWrap assists law enforcement in safely and effectively controlling encounters, especially those involving an individual experiencing a mental crisis.

Non-Lethal Weapons Market Potential

The BolaWrap Remote Restraint device is an innovative police solution, designed to provide law enforcement with a unique mobile and humane restraint option that does not inflict pain and enables subjects to be detained from a distance without the use of force.

In 2015, the 10 cities with the largest police departments in the United States paid out a cumulative $248.7 million in settlements and court judgements in police misconduct cases, marking a 48% increase from the $168.3 million in 2010 (http://nnw.fm/ri0L9). The majority of these cases have centered around the improper use of force by law enforcement when subjugating individuals, with 25% of all fatal shootings by law enforcement in the United States reportedly involving mentally ill individuals who are often incapable of comprehending officer commands (http://nnw.fm/YVm8P). Moreover, the use of alternate devices has failed to produce the desired outcomes, with the use of tasers by police resulting in over 1,080 fatalities since 2000 (http://nnw.fm/2Nb1A).

This, in turn, has led to a greater demand for humane tools which are not reliant on pain compliance to subdue subjects. Since its IPO in December 2017, Wrap Technologies has enjoyed a spectacular rise in prominence. The company began field testing the BolaWrap product in July 2018, with the first international order received only a month later, in August 2018. By December 2018, the company had been uplisted to the Nasdaq Capital Market with over 1,000 shareholders – a significant increase from the 50 shareholders who had participated in the IPO just 12 months prior. Recently, the company has sought to increase its commerciality and product monetization, appointing Tom Smith, the founder of TASER International (now Axon, NASDAQ: AAXN), as its president in March 2019.

At present, over 140 police departments throughout the United States are actively carrying the BolaWrap, while over 1,700 police departments across the nation have reached out to the company to request BolaWrap demonstrations, training and quotes. BolaWrap has also been successfully marketed internationally and has been shipped to 19 countries thus far.

As of today, Wrap Technologies has built a network of 11 distributors across 45 states in the United States who are actively marketing the product to the over 900,000 active police officers in the country. In addition, the company now has a network of 15 international distributors based in 26 countries – with over 600 international requests received thus far for product demonstrations, training and quotes.

As a result and following the opening of its new 11,000-square-foot manufacturing facility in Tempe, Arizona, in October 2019, Wrap Technologies announced a 352% year-on-year increase in revenues for 3Q2019 – a testament to the growing popularity of its mobile restraint device.

The company expects its growth to continue as adoption rates of the BolaWrap product increase throughout the United States and globally. According to a study by Stratistics MRC, the addressable global market for non-lethal weapons accounted for $6.32 billion in 2016 and is set to rise to $11.85 billion by 2023.

Product Received to Positive Acclaim

  • “An innovation that is changing the world of policing.” – Chief Luther Reynolds, Charleston Police Department
  • “Anytime you can have a more humane response to someone in crisis, it’s not only good for the department, it’s good for society.” – Redditt Hudson, Regional Field Director of the NAACP (http://nnw.fm/1STXm)
  • “This is going to save lives.” – Chief Ed Hudak, Coral Gables Police Department
  • “I see this as one of the great tools if you encounter someone with a mental health crisis.” – Chief Steven Casstevens, Buffalo Grove Police Department

Recently completed $12.4 million financing round

Wrap Technologies announced that it had successfully completed its capital raising round on June 4, 2020, raising $12.4 million through a primary share placement priced at $6.00/share. The net proceeds will be use to further scale engineering, fund product development and provide working capital to meet worldwide demand for BolaWrap products and accessories (http://nnw.fm/byLV7). The company also announced that its founder, Elwood Norris, had chosen to exercise 100,000 outstanding warrants to contribute $500,000 to the capital raising efforts. Following the financing round, Wrap Technologies reported over $30 million in cash on hand.

Management Team

Elwood G. “Woody” Norris, Founder and Chief Technology Officer
Elwood G. “Woody” Norris is an award-winning American inventor and serial entrepreneur and currently serves as chief technology officer for Wrap Technologies Inc. Norris founded and served as a director and president of Parametric Sound Corporation (now Turtle Beach Corporation (NASDAQ:HEAR)) and also served as chief scientist at Turtle Beach. Norris previously founded LRAD Corporation (NASDAQ: LRAD) and, prior to retiring in 2010, was chairman of LRAD Corporation’s board of directors, serving as a technical advisor and product spokesperson. Norris has authored more than 80 U.S. patents, primarily in the fields of electrical and acoustical engineering, and has been a frequent speaker on innovation to corporations and government organizations. He is the inventor of Wrap Technologies’ patented and patent pending BolaWrap® technology.

Scot Cohen, Executive Chairman
Scot Cohen has more than 20 years of experience in institutional asset management, wealth management, and capital markets. Cohen founded and served as principal of the Iroquois Capital Opportunity Fund, a closed-end private equity fund which focused on investments in North American oil and gas. Cohen also co-founded Iroquois Capital, a New York-based hedge fund that managed approximately $300 million across its family of funds. Prior to Iroquois Capital, Cohen founded a merchant bank which actively participated in structured investments in public companies. Cohen is currently active on a number of public and private company boards and is involved with various charitable ventures.

David Norris, Chief Executive Officer
David Norris is an experienced executive who joined Wrap Technologies full-time in January 2018. From April 2014 to December 2017, he served in various executive roles, including president, at privately held loanDepot LLC as it rapidly expanded into the fifth largest mortgage lender in the U.S. loanDepot had 6,000 employees and generated $1 billion in revenue in 2017. Norris also served as CEO of Greenlight Financial, and president of LendingTree Loans. Norris’ career also includes executive and management roles at Toshiba America Information Systems and Qualcomm Personal. Earlier in his career, Norris served as a probation officer in San Diego for five years.

Tom Smith, President
Tom Smith co-founded TASER International (now Axon Enterprise Inc. (NASDAQ: AAXN)) (“TASER”) in 1993 and served as president of TASER until October 2006. He served as chairman of the board of directors of TASER from October 2006 until he retired to pursue entrepreneurial activities in February 2012. Amongst his most significant roles and responsibilities at TASER, Smith managed domestic and international sales, significantly expanding the sale and distribution of TASER’s products, including sales to more than 17,200 federal, state and local law enforcement agencies in over 100 countries. In 2012, he founded Achilles Technology Solutions LLC, which, through subsidiary ATS Armor, developed a line of ballistic solutions for law enforcement and military applications. Smith holds a B.S. in ecology and evolutionary biology from the University of Arizona and an M.B.A. from Northern Arizona University.

Jim Barnes, Chief Financial Officer
Jim Barnes has served as president of Sunrise Capital Inc., a private venture capital and financial and regulatory consulting firm, since 1984. Barnes was chief financial officer of Parametric Sound Corporation (now Turtle Beach Corporation), and also served as vice president administration at Turtle Beach Corporation. Since 1999, Barnes has been manager of Syzygy Licensing LLC, a private technology invention and licensing company he owns with Elwood Norris. Barnes previously practiced as a certified public accountant and management consultant with Ernst & Ernst and Touche Ross & Co., and as a principal in J. McDonald & Co. Ltd. in Phoenix, Arizona.

Wrap Technologies Inc. (NASDAQ: WRTC), closed Tuesday's trading session at $10.48, up 6.288%, on 1,655,070 volume with 8,954 trades. The average volume for the last 3 months is 1,016,257 and the stock's 52-week low/high is $3.06999993/$10.8800001.

Recent News

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK)

The QualityStocks Daily Newsletter would like to spotlight iClick Interactive Asia Group Ltd. (NASDAQ: ICLK).

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it has been named winner of the Big Data Award in the advertising category at Singapore Business Review's ("SBR") second Technology Excellence Awards 2020. Held annually by SBR, a leading business magazine serving Singapore's dynamic business community, the Technology Excellence Awards recognize outstanding companies worldwide that have made exceptional contributions in pursuit of technological innovation. To view the full press release, visit http://nnw.fm/jQFM1

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider connecting worldwide marketers with audiences in China. Built on cutting-edge technologies, iClick’s proprietary platform possesses omni-channel marketing capabilities and fulfills various marketing objectives in a data-driven and automated manner, helping international and domestic marketers reach their target audiences. Headquartered in Hong Kong, iClick operates in 10 locations worldwide, including Asia and Europe.

iClick aims to become a fully integrated Enterprise and Marketing Cloud Platform in China, providing clients a full consumer-cycle solution. This is facilitated by two pillars’ growth strategy through two business segments: Marketing Solutions and Enterprise Solutions.

Marketing Solutions

Using data and AI-driven technology to help brands efficiently identify, target and acquire the right customers

As the leading programmatic marketing platform in China, iClick’s proprietary platform collects a wealth of data from multiple sources to precisely reach the right audience at the right moment, on the right channel and right device. Cross-screen search solutions capture critical micro-moments when users proactively search for what they need. This multi-dimensional approach to marketing allows iClick to effectively understand internet users and exponentially widen target audiences for its brand clients. Multiple monetization models available in the Marketing Solutions segment allow iClick to serve its clients in several ways, such as audience targeting.

Data-driven marketing is indispensable to marketers targeting specific audiences in China. More than 825 million internet users in China are anonymously profiled on iClick’s platform, which boasts cross-channel and cross-screen capabilities.

Enterprise Solutions

Enabling brands to efficiently manage their consumers through online and offline data integration and analysis, increase the repurchase rate, and enhance consumers’ loyalty

iClick’s Enterprise Solutions segment addresses enterprise needs in China, particularly focusing on “smart retail,” an expanding and innovating market involving the combination of online and offline consumers’ behavioral information. Enterprise Solutions support detailed profiling of customers, which facilitates data-driven business strategies, enhances business processes at various levels, and increases operational and marketing efficiency.

Enterprise Solutions leverages iClick’s proprietary platform that incorporates Artificial Intelligence (AI) to learn, build and store knowledge, enabling accurate predictions about consumer behavior that ultimately provide marketing solutions derived from the large amount of available data.

Through a strategic partnership with Tencent, iClick’s Enterprise Solutions presents strong recurring revenue streams with tremendous opportunities to upsell multi-national corporations (MNCs). Tencent’s proprietary API connection enables brands to build 360-degree consumer profiles based on the collection and integration of purchased behavioral information from online and offline touchpoints, including WeChat Mini Programs, WeChat Payment, WeChat Work and more.

As iClick continues to provide integrated marketing and smart retail solutions targeting Chinese consumers, the company believes Enterprise Solutions has strong long-term growth potential and will become a major gross margin contributor in the future.

Partnerships

In 2019, iClick established various agreements and partnerships with a number of leading southeast and northeast Asian companies for regional diversification and in 2020 is focused on continuing to develop additional partnerships and new business models globally. Many of the world’s top companies are leveraging iClick’s proprietary data platform to precisely identify and reach out to core target audience groups in China.

The company’s partnerships include:

  • A tri-partnership with BTG WELINK, an online retail services arm of Beijing Tourism Group (“BTG”), and Tencent Holdings Ltd., China’s leading provider of internet value added services. As part of this partnership, iClick applies its upgraded solutions to build a private DSP (Demand Side Platform) system for BTG. Using Tencent’s big data advertising platform, iClick can assist BTG to develop precision marketing campaigns.
  • An Advertising Agency Authorization Certificate from Baidu Inc. (NASDAQ: BIDU), under which iClick is designated the authorized agency for native advertising of Baidu’s news feed ads. Native advertising is a consumer-friendly, non-disruptive advertising format that has gained rapid popularity among advertisers in recent years. Native advertising and creative marketing content have become a more effective marketing method among the Chinese young consumers. In 2019, the native advertising sector was estimated to have an around 53.5% share of the online advertising revenue, according to Statista.
  • A joint-venture partnership with VGI Global Media Plc (VGI.BKK), Thailand’s No. 1 online to offline (O2O) solutions provider across advertising, payment and logistics platforms, which enables brands in Southeast Asia to capture the multi-billion-dollar Chinese consumer market through a range of technology-driven marketing solutions.

Case Study: Armani Hotel Dubai

Dubai has been gearing up to welcome the growing wave of Chinese visitors. Chinese nationals are eligible for a 30-day visa-on-arrival into the UAE, which gives Chinese travelers tremendous convenience. In light of this, Armani Hotel Dubai set the objective to increase its sales in this market.

The challenge: What Aarmani Hotel Dubai lacked in executing this goal was insightful understanding of Chinese travelers in particular the demographics that were likely to be attracted to the hotel. Challenged by the huge differences in the business practice, unique culture and language barrier in running digital campaigns in China, Armani Hotel Dubai turned to iClick’s know-how and expertise to guide its campaign to success and meet its sales goal.

The solution: iClick tailored an optimal solution for the hotel to increase brand awareness and booking rate from China – which is the key market for the hotel – and successfully assisted Armani Hotel Dubai in reaching its target Chinese audiences by using China’s most popular mobile and internet sites, including WeChat and Weibo, to improve reach and booking potential.

The results: Due to iClick’s unrivaled technological and execution strengths, Armani Hotel Dubai’s ads were delivered in an omnichannel manner, raising brand awareness and garnering interest between Chinese consumers. Subsequently, Armani Hotel Dubai saw a surge in conversion rate.
During the campaign, the Armani Hotel Dubai brand was connected with 87% of Chinese mobile users.

Award-winning Provider

iClick, a Deloitte Technology Fast50, has received multiple industry awards from the international marketing community. The company is committed to helping clients access digital China with its omni-channel, data-driven marketing solutions that deliver uniquely sharpened marketing capabilities and outstanding advertising results.

Most recently, iClick subsidiary OptAim (Beijing) Information Technology Co., Ltd was recognized by Tencent Ads as a 2019 Gold Service Provider. Tencent Ads also named OptAim the winner of three major annual awards for the second half of 2019: “Outstanding Contribution of the Year,” “Best Technology & Data Application Award,” and “Best Branding Awards.”

In November 2019, company co-founder and CEO Sammy Hsieh was chosen as the winner of the “EY Entrepreneur of The Year China 2019 Award in Technology Category,” an award recognizing his entrepreneurial acumen, innovative spirit and strong leadership. As one of the world’s most prestigious business accolades, the “EY Entrepreneur of The Year” awards program honors those who accomplish success by combining ability with opportunity, and inspire others with great vision, leadership and outstanding achievement.

iClick won the Annual Influential Platform Award and the Innovation Golden Award in Marketing at the Creative Award 2019, as well as the Best Tourism Marketing Agency. The company was also the recipient of the “Best Brand and Performance Marketing Award” at the Performance Marketing Ecosystem Summit 2018 hosted by the Advertising & Marketing Service, a division of Tencent Holdings Limited.

The company in 2018 was also recognized as “Platinum Service Partner of Tencent Social Ads” at the Tencent Key Accounts Mid-Year Summit held in Beijing. The mobile division of iClick, Optaim, received the same award beginning in 2016. Optaim was also the “Best DSP Partner” and “Key Account Data Partner” of Tencent, making it the only player in China with such unique and deep level of cooperation with Tencent Social Ads.

Leadership

Sammy Wing Hong Hsieh, chairman of the board and co-founder, was CEO from 2009 to 2019. Prior to co-founding iClick, Hsieh held senior positions in several prominent technology companies. He was general manager for Asia Pacific at Efficient Frontier (now an Adobe company), a leading digital performance marketing company, and was director of Search Marketing at Yahoo Hong Kong from 2000-2008. Hsieh received a bachelor’s degree in economics from the University of California, Los Angeles.

Jian Tang, director, CEO and co-founder, has 20 years of experience in digital advertising and is well-known in China for his expertise in advertising technologies and big data. In 2012, he founded OptAim, which was acquired by iClick in 2015, and has served key research, engineering and management roles at Yahoo’s global research and development center. Tang received his doctorate in computer engineering from Tsinghua University and was named by Campaign Asia as one of the leaders in its Digital A-List in 2016.

Terence Chi Wai Li, chief financial officer, has 15 years of experience in financial management, investment and business operations. He has served in management roles and advisory capacities at several start-ups, in addition to financial management and fundraising roles. He previously worked at PricewaterhouseCoopers, specializing in M&A due diligence and cross border tax and deal structuring projects. Li received an MBA from Oxford University’s Said Business School. He is a Fellow Member of ACCA, a Member of HKICPA, and a Chartered Financial Analyst.

iClick Interactive Asia Group Ltd. (NASDAQ: ICLK), closed Tuesday's trading session at $5.33, up 1.3308%, on 437,065 volume with 2,602 trades. The average volume for the last 3 months is 468,928 and the stock's 52-week low/high is $2.73000001/$5.98999977.

Recent News

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) was featured in today's edition of the Investorideas.com potcastsCM. Listen to the podcast: http://ibn.fm/pLog5

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Tuesday's trading session at $0.7922, off by 0.851064%, on 55,631 volume with 91 trades. The average volume for the last 3 months is 75,315 and the stock's 52-week low/high is $0.371499985/$2.83999991.

Recent News

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (OTCQB: NUGS).

Cannabis Strategic Ventures, Inc. (NUGS) was highlighted today in a publication from FinancialNewsMedia.com, examining how the global health crisis has actually increased the sales of cannabis-infused products. New reports reveal cannabis consumers in the United States are becoming more interested in cannabis-infused products. The latest report from New Frontier Data projects that 17 percent of U.S. spending on legal cannabis in 2020 will be on cannabis-infused products like edibles, sodas, and topicals. The report said that in total, U.S. consumer spending on legal cannabis will grow by 25 percent in 2020 to exceed $18 billion. 

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), closed Tuesday's trading session at $0.0787, up 0.510856%, on 1,566,073 volume with 142 trades. The average volume for the last 3 months is 1,606,642 and the stock's 52-week low/high is $0.025499999/$0.600000023.

Recent News

Cannabis Global, Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Global, Inc. (MCTC).

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced the launch of its newest line of branded products, Hemp & Booch Super Premium hemp-infused Kombucha. To view the full press release, visit http://cnw.fm/JdRW2. Also today, the company was highlighted in a publication from FinancialNewsMedia.com, examining how the latest report  from New Frontier Data projects that 17 percent of U.S. spending on legal cannabis in 2020 will be on cannabis-infused products like edibles, sodas, and topicals. 

Cannabis Global, Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

Cannabis Global, Inc. (MCTC), closed Tuesday's trading session at $0.2689, up 3.5425%, on 32,925 volume with 15 trades. The average volume for the last 3 months is 61,159 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile Inc. (TSX-V:SIM / OTCQX:SYATF/ FRA: WK3D) announces it has filed its Q1 2020 financials and will be hosting an investor conference call on Thursday, July 2nd at 9:00 AM EDT (6:00 AM PDT) to discuss these results followed by a Q&A for investors.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Tuesday's trading session at $0.0792, up 11.3924%, on 122,215 volume with 14 trades. The average volume for the last 3 months is 159,199 and the stock's 52-week low/high is $0.07/$0.384000003.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.